We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Genentech's Rituxan, Others, Under Fire From Sanofi

Law360 (October 27, 2008, 12:00 AM EDT) -- Germany-based pharmaceutical company Sanofi-Aventis Deutschland GmbH has sued Genentech Inc. and Biogen Idec Inc. over two patents allegedly infringed by the companies' manufacture and sale of drugs used to treat diseases including cancer, pulmonary embolism and cystic fibrosis.

Genentech's nonexclusive license to make use of the two patents-at-issue is set to terminate on Monday, according to the complaint filed the same day in the U.S. District Court for the Eastern District of Texas.

Genentech has produced several drugs using mammalian cell suspension cultures that utilize the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.